81 results on '"Doraiswamy, P."'
Search Results
2. You Can’t Manage What You Do Not Measure - Why Adolescent Mental Health Monitoring Matters
3. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
4. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
5. Metabolic network failures in Alzheimer's disease: A biochemical road map
6. Single-nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients
7. A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings
8. Marked gender differences in progression of mild cognitive impairment over 8 years
9. Comparison of Brain Structural Variables, Neuropsychological Factors, and Treatment Outcome in Early-Onset Versus Late-Onset Late-Life Depression
10. Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): Clinical rationale and design
11. Brain atrophy rates in first degree relatives at risk for Alzheimer's
12. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
13. Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth
14. Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals
15. Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack
16. Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial
17. Cognitive Improvement Following Treatment in Late-Life Depression: Relationship to Vascular Risk and Age of Onset
18. Metabolomic changes in autopsy-confirmed Alzheimer's disease
19. One-Year Change in Anterior Cingulate Cortex White Matter Microstructure: Relationship With Late-Life Depression Outcomes
20. Modulation of a Human Memory Circuit by Subsyndromal Depression in Late Life: A Functional Magnetic Resonance Imaging Study
21. Predicting memory decline in normal elderly: Genetics, MRI, and cognitive reserve
22. Accuracy of spatial normalization of the hippocampus: Implications for fMRI research in memory disorders
23. Cognitive Function in Late Life Depression: Relationships to Depression Severity, Cerebrovascular Risk Factors and Processing Speed
24. A Review of 1H MR Spectroscopy Findings in Alzheimer's Disease
25. Current Status of Functional MR Imaging, Perfusion-Weighted Imaging, and Diffusion-Tensor Imaging in Alzheimer's Disease Diagnosis and Research
26. Session 208 - Therapeutic Strategies in Depression with Cognitive Impairment
27. Quality of Life in Geriatric Depression: A Comparison of Remitters, Partial Responders, and Nonresponders
28. Clinical and treatment response characteristics of late-life associated with vascular disease: A pooled analysis of two multicenter trials with sertraline
29. SERUM TRIGLYCERIDES IN ALZHEIMER'S DISEASE: RELATION TO NEUROIMAGING, CSF, AND GENETIC VARIATION
30. ASSOCIATION OF SERUM-BASED PLASMALOGENS WITH NEUROIMAGING AND GENETIC VARIATION IN ALZHEIMER’S DISEASE
31. Chapter 14 - Dementia Clinical Research in India
32. ALTERED BILE ACID METABOLITES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE: RELATION TO NEUROIMAGING AND CSF BIOMARKERS
33. The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors
34. Cerebrovascular Risk Factors and Cerebral Hyperintensities among Middle-Aged and Older Adults With Major Depression
35. THE ALZHEIMER’S METABOLOME: RELATIONSHIP TO PATHOLOGICAL MARKERS AND COGNITIVE DECLINE IN THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE (ADNI)
36. The Alzheimer’s metabolome: Identification of novel markers and treatment targets
37. Marked gender differences in rate of cognitive decline in subjects at risk for Alzheimer’s disease
38. WHOLE GENE-BASED ASSOCIATION OF BASELINE PLASMA HOMOCYSTEINE IN THE ADNI-1 COHORT
39. EVALUATION OF EVENT RELATED POTENTIALS AND QUANTITATIVE EEG AS USEFUL BIOMARKERS FOR THE DIAGNOSIS OF EARLY-STAGE ALZHEIMER'S DISEASE
40. Alterations in metabolic pathways and networks in mild cognitive impairment and early Alzheimer's disease
41. A multicenter clinical trial to validate event-related potentials as useful biomarkers for early detection of Alzheimer's disease
42. Targeted lipidomic-pathway–guided genetic association with Alzheimer's disease–relevant endophenotypes
43. Analysis of relationships between cortical structural connections, global and local amyloid burden, and cognitive performace in Alzheimer's dementia
44. Analysis of relationships between cortical structural connections, global and local amyloid burden and cognitive performance in Alzheimer's dementia
45. Targeted lipidomic pathway-guided genetic association with Alzheimer's disease–relevant endophenotypes
46. Relationship of Florbetapir F18 PET Amyloid Plaque Neuroimaging with Future Cognitive Decline over 36 Months
47. Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies
48. Prognostic significance of Florbetapir (18F-Florbetapir) PET imaging for future cognitive performance in recently diagnosed MCI: Final results from a 3-year multicenter longitudinal trial
49. A multicenter clinical trial to validate Event-Related Potentials (ERPs) as useful biomarkers for early detection of Alzheimer's
50. Robust postmortem correlates of florbetapir-PET beta-amyloid imaging of Alzheimer's disease subjects despite neuropathologic heterogeneity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.